Dr. Ortega legaspi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
# 2
Philadelphia, PA 19104Phone+1 215-615-4949
Education & Training
- University of WashingtonFellowship, Cardiovascular Disease, 2013 - 2016
- Emory University School of MedicineResidency, Internal Medicine, 2010 - 2013
- Universidad Nacional Autónoma de MéxicoPhD, 2007 - 2010
- Universidad Nacional Autonoma de MexicoClass of 2008
Certifications & Licensure
- FL State Medical License 2022 - Present
- PA State Medical License 2018 - 2026
- WA State Medical License 2013 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- American College of Cardiology 3T Teaching Tomorrow’s Teachers, 2016
- Bruce-Laughlin Endowed Fellowship University of Washington, 2016
- Bursary for the Third International Congress on Neuropathic Pain 2010
- Join now to see all
Publications & Presentations
PubMed
- Safety and Efficacy of GLP-1 Agonists in a Cohort of Patients with Fontan Circulation.Andrew M Freddo, Humera Ahmed, Jonathan B Edelson, Juan M Ortega-Legaspi, Sumeet Vaikunth
Pediatric Cardiology. 2024-11-12 - Hemodynamic Support With the Impella 5.5 Acute Mechanical Circulatory Support Device.James W Schurr, Adrian Pearson, Matthew S Delfiner, Alyson Brown, Mary Frances Quinn
ASAIO Journal. 2024-10-15 - 1 citationsMortality and morbidity after combined heart and liver transplantation in the failing Fontan: An updated dual center retrospective study.Sumeet S Vaikunth, Juan M Ortega-Legaspi, Desiree R Conrad, Sharon Chen, Tami Daugherty
Clinical Transplantation. 2024-04-01
Journal Articles
- Acute myocarditis following high-dose interleukin-2 treatmentTan MChC, Ortega-Legaspi JM, Cheng SF, Patton KK, J Cardiol Cases, 1/1/2017
- Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatientsHayek SS, Abdou MH, Demoss BD, Ortega-Legaspi JM, Veledar E, Deka A, Krishnan SK, Wilmot KA, Patel AD, Kumar VR, Devireddy CM, Am J Hypertens, 1/1/2013
- Alginate microencapsulation of human mesenchymal stem cells as a strategy to enhance paracrine-mediated vascular recovery after hind limb ischemiaLandázuri N, Levit RD, Joseph G, Ortega-Legaspi JM, Flores CA, Weiss D, Sambanis A, Weber CJ, Safley SA, Taylor WR, J Tissue Eng Regen Med, 1/21/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Major Histocompatibility Complex-I Deficient Embryonic Stem Cell Derived Cardiomyocytes as Potential off-the-Shelf Therapy for Cardiac RegenerationOrtega-Legaspi JM, Chyu J, Zhang Y, El-Nachef D, Oyama K, Gornalusse GG, Russell DW, MacLellan WR, International Society for Stem Cell Research, Boston, MA, 1/1/2017
- Echocardiographic Findings in Continuous-Flow Left Ventricular Assist Device Pump ThrombosisOrtega-Legaspi JM, Airhart S, Nguyen H, Masri SC, Mokadam NA, Mahr C, Kirkpatrick JN, Heart Failure Society of America 20th Annual Scientific Meeting, Orlando, FL, 1/1/2016
- Major Histocompatibility Complex-I Deficient Embryonic Stem Cell-Derived Cardiomyocytes as Potential Off The-Shelf Therapy For Cardiac RegenerationOrtega-Legaspi JM, Chyiu J, de la Mata A, MacLellan WR, World Congress of Cardiology and Cardiovascular Health. World Heart Federation, Mexico City, 1/1/2016
- Join now to see all
Lectures
- Cells Therapy and Cardiovascular DiseaseUniversity of Washington - 1/1/2017
- Inicio y seguimiento del tratamiento inmunosupresor del paciente pos-trasplante (Initiation and following of immunosuppressive therapy in post transplant patients)Jalisco, México - 1/1/2017
- Apoyo Mecánico Circulatorio en Pacientes con Insuficiencia Cardíaca Terminal (Mechanical Circulatory Support in Patients with End Stage Heart Failure)Jalisco, México - 1/1/2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: